Dr. Majithia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
800 Washington St
Boston, MA 02111Phone+1 201-543-7064
Education & Training
- Brigham and Womens HospitalFellowship, Structural and Peripheral Cardiology, 2018 - 2020
- Lahey ClinicFellowship, Cardiovascular Disease, 2014 - 2018
- Tufts Medical CenterResidency, Internal Medicine, 2011 - 2014
- New York University School of MedicineClass of 2011
- Brigham and Women's HospitalFellowship, Interventional Cardiology
Certifications & Licensure
- NH State Medical License 2024 - 2026
- MA State Medical License 2014 - 2025
- RI State Medical License 2019 - 2020
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Cardiovascular Disease
- American Board of Internal Medicine Interventional Cardiology
Publications & Presentations
PubMed
- 42 citationsNovel Antiplatelet Therapies for Atherothrombotic Diseases.Arjun Majithia, Deepak L. Bhatt
Arteriosclerosis, Thrombosis, and Vascular Biology. 2019-04-01 - 54 citationsRegistry-Based Prospective, Active Surveillance of Medical-Device SafetyFrederic S. Resnic, Arjun Majithia, Danica Marinac-Dabic, Susan Robbins, Henry Ssemaganda
The New England Journal of Medicine. 2017-01-25 - 7 citationsActive Surveillance of the Implantable Cardioverter-Defibrillator Registry for Defibrillator Lead FailuresFrederic S. Resnic, Arjun Majithia, Sanket S. Dhruva, Henry Ssemaganda, Susan Robbins
Circulation. Cardiovascular Quality and Outcomes. 2020-04-14
Authored Content
- SCAI 2021: What's New in Complex Coronary Stent ProceduresMay 2021
Press Mentions
- Early Feasibility Studies for Cardiovascular Devices in the United StatesNovember 30th, 2020
- U.S. Veterans with Decreased Renal Function Shown to Be at Higher Risk for Adverse Cardiovascular Events if They Have Moderately Elevated Triglyceride (TG) Levels Despite Well-Controlled Low-Density Lipoprotein (LDL)-CholesterolOctober 23rd, 2020
- Ablative Solutions Announces Publication of Data from the Peregrine Post-Market StudyFebruary 21st, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: